Home / Clinical Decision Support & Reference / syngo.CT Extended Functionality

syngo.CT Extended Functionality

by Siemens Medical Solutions USA · Based in United States →

Cardiology Radiology Vascular Surgery

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Contact for pricing

Regulatory Status Disclosed

Overview

syngo.CT Extended Functionality by Siemens Medical Solutions USA is an advanced visualization and post-processing software package designed to support radiological workflows. It provides clinicians and technologists with tools to prepare, process, and analyze medical images for diagnostic purposes, primarily utilizing data acquired from computed tomography (CT) scanners as well as other imaging modalities such as magnetic resonance (MR) scanners.

The software is built for radiologists, imaging technicians, and specialists across acute care, oncology, and outpatient imaging environments. It integrates directly with interconnected CT scanner systems and PACS platforms to streamline clinical workflows, enabling efficient multi-modality reading and diagnostic preparation.

Notable capabilities of the platform include:

Qualitative and Quantitative Analysis: Tools for precise anatomical measurements and clinical data evaluation.
Pulmonary Density Analysis: A dedicated plug-in designed to assist in the evaluation and quantification of infectious lung diseases by measuring lung volume and lesion opacities.
syngo.CT Neuro DSA: A specialized post-processing application that automatically removes bone structures from CT angiography (CTA) datasets of cerebral vasculature using a non-enhanced CT mask.
Interactive Spectral Imaging: Functionality that allows clinicians to display and analyze different spectral imaging datasets.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Advanced visualization tools for medical images
Qualitative and quantitative measurements
Analysis of clinical data from CT and other modalities (e.g., MR)
Bone removal algorithms (e.g., for CT Angiography)
Phase creation (e.g., arterial or venous phases)
Motion correction to reduce artifacts
4D Noise Reduction for improved image quality
Table removal for clearer vessel visualization
Evaluation of time attenuation curves
Interactive Segmentation Tools (e.g., Region Growing, Automatic Organ segmentation)

Use Cases

Assisting in diagnosis based on CT and multi-modality images
Vascular analysis and visualization of blood flow (e.g., aneurysms, vascular malformations, tumor vascularization)
Oncological reading and lesion evaluation (lungs, liver, lymph nodes) with standardized quantification (RECIST, WHO, volume)
Neurological examinations (e.g., brain hemorrhage, perfusion analysis for ischemic stroke, bone removal for cerebral vasculature)
Cardiology applications (e.g., hybrid coronary view, myocardial surface projections, plaque visualization)
Kidney stone evaluation and differentiation between uric acid and non-uric acid stones

What Physicians Need to Know

Evidence Base

syngo.CT Extended Functionality, as part of the syngo.via platform, provides advanced visualization and quantitative tools to assist physicians in diagnosis and treatment planning. The broader syngo.via platform integrates evidence-based, structured reporting with diagnostic guidelines such as TNM staging, Lung RADS, CAD RADS, and LI RADS. Clinical literature, including the National Lung Screening Trial results, is referenced for specific applications like low-dose lung cancer screening.

Clinical Validation Studies

Non-clinical integration and functional tests were conducted during product development, demonstrating that the device performs as intended. Verification and validation testing supported modifications and established substantial equivalence to predicate devices. A deep learning-based autocontouring solution within syngo.via RT Image Suite (related to syngo.CT Extended Functionality) has been clinically validated, showing good results and significant time savings in delineating organs at risk, with 64% of evaluated structures receiving the maximum score.

Alert Fatigue Management

This topic is not explicitly addressed in the provided information for syngo.CT Extended Functionality, as its primary role is advanced visualization and quantification rather than generating traditional diagnostic alerts.

Differential Diagnosis Support

The tool provides advanced visualization and quantitative measurement capabilities to aid in diagnostic processes. Specific functionalities include estimating infarct core and penumbra in ischemic stroke (syngo.CT Neuro Perfusion), visualizing uric acid crystals for gout diagnosis (syngo.CT DE Gout), and assisting in colorectal cancer detection (syngo.CT Colonography). It also offers automatic evaluation of cardiac function and highlights ischemic areas (syngo.CT Cardiac Function). The broader syngo.via platform supports automated segmentation and evaluation of lesions in various organs, providing standardized quantification (e.g., RECIST, WHO, volume) to support differential diagnosis.

Clinical Workflow Integration

syngo.CT Extended Functionality is designed to integrate seamlessly into clinical workflows, connecting with CT scanners and potentially other imaging modalities like MR. It integrates with existing PACS and RIS systems. Features like 'Automated Case Preparation' automatically load images into appropriate applications and sort them into disease-specific layouts, while 'Case Navigator' and 'Findings Navigator' streamline structured workflow and tracking of findings. The syngo.via platform, which encompasses this functionality, acts as a client-server solution orchestrating the imaging workflow from acquisition to reading and sharing, making cases instantly available from various locations, including PACS. Rapid Results Technology automates post-processing and can transfer results to PACS without user interaction.

Decision Audit Trail

The syngo platform includes security features that log relevant data security information in an audit trail. An 'Audit Trail Filter' is available to view, search, and generate reports from audit trail files, indicating that user actions and system activities are recorded.

Physician Tip

Leverage the advanced visualization and quantitative analysis tools of syngo.CT Extended Functionality to enhance diagnostic confidence and efficiency, particularly for complex cases in cardiology, neurology, and oncology. Utilize automated case preparation and structured workflow features to streamline image review and reporting. Integrate the quantitative measurements and standardized reporting capabilities to support evidence-based decision-making and facilitate communication with referring physicians. Explore specific applications like Neuro Perfusion or DE Gout for targeted diagnostic insights. Remember that while the software provides powerful analytical support, clinical correlation and physician expertise remain paramount for final diagnosis and treatment planning.

syngo.CT Extended Functionality is part of the broader Siemens syngo.via platform, designed for seamless integration with Siemens CT scanners and potentially other imaging modalities (e.g., MR). It integrates with existing Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) to ensure a unified workflow and access to patient data. The client-server architecture of syngo.via enables image access and sharing across various workstations and mobile devices. It also supports the export of data, such as DICOM RT Structures for radiation therapy planning, facilitating interdepartmental collaboration.

At a glance

Pricing Contact for pricing

Deployment On Premise Workstation Software, Potentially Integrating With Client Server Solutions Like Syngo.via

Visit site

Details

Category	Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing	Contact for pricing
Deployment	On-premise workstation software, potentially integrating with client-server solutions like syngo.via
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	1 AI-estimated syngo.CT Extended Functionality received FDA 510(k) clearance (K221727) on July 13, 2022. It is intended to provide advanced visualization tools to prepare and process medical images for diagnostic purposes, supporting technicians and physicians in qualitative and quantitative measurements and analysis of clinical data from CT and other medical imaging modalities.
Integrations
EHR	Not specified
Specialties	Cardiology, Radiology, Vascular Surgery

What the Web Says

syngo.CT Extended Functionality is a Siemens Healthineers software package designed to provide advanced visualization tools for processing and analyzing medical images from CT scanners and other modalities. It aims to support technicians and physicians in qualitative and quantitative measurements for diagnostic purposes. The software has undergone several FDA clearances, indicating its ongoing development and expansion of features, including AI algorithms for specific applications like lung density analysis in COVID-19 patients.

Overall: Mixed

Strengths

Provides advanced visualization tools for CT and other medical imaging modalities.
Supports qualitative and quantitative measurements and analysis of clinical data.
Includes specialized applications for various clinical evaluations (e.g., cardiac, vascular, dual energy, neuro DSA).
Features AI algorithms for automated analysis, such as lung lobe segmentation and volumetric measurement of lung lesions.
Designed to integrate into existing IT environments and offers multi-modality reading functionality.
Regular software upgrades and updates are provided for enhanced features and productivity.

Limitations

Specific user reviews and opinions from physicians, healthcare IT, tech reviewers, Reddit, G2, and Capterra are not readily available in the search results.
Details on the types of data used for retraining AI models are limited in some FDA approvals.
The availability of certain features may vary due to regulatory reasons.
The search results primarily consist of FDA clearance documents and product datasheets, lacking independent user feedback.

Based on reviews from: accessdata.fda.gov, fda.gov, Innolitics, arXiv, FDA.report, AuntMinnie, PMC

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate syngo.CT Extended Functionality

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

FDA.gov

syngo.CT Extended Functionality 510(k) Clearance (K221727)

This regulatory announcement details the FDA 510(k) clearance for syngo.CT Extended Functionality, affirming its substantial equivalence to predicate devices for advanced visualization and image processing in CT. The submission highlights improvements in the bone removal algorithm using deep learning.

2022-01

Siemens Healthineers USA

syngo.via View&GO - Siemens Healthineers USA

This page describes syngo.via View&GO, which includes parts of syngo.CT Extended Functionality, highlighting improvements like a new user interface ('SHUI'), an updated 'Assisted Perpendicular Tool,' and the 'TimeCurve Tool' for multi-modality reading. It also mentions the Pulmonary Density Plug-In as part of syngo.CT Extended Functionality.

2026-07

FDA.gov

syngo.CT Extended Functionality 510(k) Clearance (K212889)

This FDA 510(k) clearance for syngo.CT Extended Functionality confirms its intended use for advanced visualization and image processing, stating it is as safe and effective as commercially available predicate devices. It details the software's ability to accept and display additional CT scanner datasets and mean values of ROIs.

2022-07

Siemens Healthineers USA

AI COVID-19 - Siemens Healthineers USA

This article discusses the 'Pulmonary-Density Plug-In,' part of syngo.CT Extended Functionality, which received CE-labeling and FDA enforcement policy approval during the COVID-19 pandemic for automated quantification of abnormalities in chest CTs. It emphasizes the tool's efficiency and user-friendliness for radiologists.

2020-04

FDA.gov

syngo.CT Extended Functionality 510(k) Clearance (K192402)

This regulatory document outlines the FDA 510(k) clearance for syngo.CT Extended Functionality, describing it as a software bundle offering tools for special clinical evaluations and advanced visualizations and measurements on CT and other medical imaging data.

2019-09

PMC (PubMed Central)

Artificial intelligence algorithms based approach in evaluating COVID-19 patients and management

This peer-reviewed article highlights the use of Siemens Healthineers' AI software, integrated into the CT Pulmonary Density module (part of syngo.CT Extended Functionality), for automated lung segmentation and volumetric measurement in COVID-19 patients. The software provides an accurate severity score for each lung lobe.

2025-07

medRxiv

Regulating AI Adaptation: An Analysis of AI Medical Device Updates

This pre-print article analyzes regulatory aspects of AI medical device updates, citing FDA approval K221727 for syngo.CT Extended Functionality as an example where the bone removal algorithm was improved using a deep learning algorithm instead of traditional image processing.

2024-06

Siemens Healthineers

syngo.via VB40A Datasheet

This datasheet details syngo.via's capabilities, including its connection to syngo.CT Extended Functionality for advanced visualization tools. It mentions features like syngo.via Time Curve Tool and syngo.via CT Lung Change, which enhance reading workflows and provide disease-specific applications.

unknown

Videos

Product demos, reviews, and walkthroughs for syngo.CT Extended Functionality.

Spectral Results with every scan at Hennepin County Medical Center

Philips Healthcare

Expanding clinical boundaries with Philips Spectral CT

Philips Healthcare

Siemens ARCADIS Orbic 3D C-arm

GMEDX

View all on YouTube

Frequently Asked Questions

How does syngo.CT Extended Functionality leverage AI to improve diagnostic workflows?

syngo.CT Extended Functionality, particularly through its integration with platforms like syngo.via, utilizes AI to automate and streamline various post-processing steps, enhancing efficiency and reducing manual effort in image interpretation. This includes AI-powered applications for faster 3D results, standardized quantifications, and reduced inter-reader variability, allowing physicians to start reading cases more quickly.

What specific AI-powered applications are included within syngo.CT Extended Functionality, and what are their clinical benefits?

Specific AI-powered applications include syngo.CT Coronary Cockpit for automated plaque analysis in coronary artery disease, which quantifies and characterizes plaque burden to aid risk assessment and PCI planning. Another example is the CT Pneumonia Analysis prototype, which assists in evaluating the extent and mapping of pneumonia, crucial for conditions like COVID-19.

What regulatory clearances and compliance standards does syngo.CT Extended Functionality meet, especially concerning AI components and data privacy?

syngo.CT Extended Functionality has received FDA clearance, indicating it is considered safe and effective for its intended diagnostic purpose, with testing demonstrating substantial equivalence to predicate devices. While specific data privacy compliance (like HIPAA or GDPR) isn't detailed in the provided snippets, medical devices in the US must adhere to FDA regulations, including those for software and quality systems.

Are there alternative AI-driven CT imaging solutions available, and how does syngo.CT Extended Functionality differentiate itself?

Yes, there are alternative PACS and enterprise imaging solutions that incorporate AI-powered analytics, such as PACScribe, Ambra Health, and NovaPACS EI. syngo.CT Extended Functionality, especially through syngo.via, differentiates itself by offering a broad AI portfolio across multiple modalities, seamless integration with Siemens CT systems, and open access to a growing variety of clinical applications from Siemens and partners via syngo.via OpenApps.

What are the typical pricing or licensing models for syngo.CT Extended Functionality, particularly for its AI features?

While specific pricing for syngo.CT Extended Functionality's AI features is not publicly detailed, the syngo.via platform, which integrates many of these functionalities, offers a subscription model. This model aims to optimize costs, provide flexible clinical package access, and ensure evergreen software with access to innovations, service, and education plans.

What are the known limitations or potential biases of the AI algorithms within syngo.CT Extended Functionality that physicians should be aware of?

The information provided does not explicitly detail specific limitations or biases of the AI algorithms within syngo.CT Extended Functionality. However, it is generally stated that resulting images and analyses are intended to *assist* trained technicians or physicians in diagnosis, implying that the final diagnosis remains the responsibility of the clinician. For instance, in kidney stone analysis, additional clinical information like patient history and urine testing should be considered, and accuracy may decrease in obese patients.

Compare syngo.CT Extended Functionality

Transpara vs syngo.CT Extended Functionality

Clinical Decision Support & Reference Adjacent · 65/100

Transpara is an AI-powered solution specifically designed for breast cancer detection and workflow optimization in 2D and 3D mammography. In contrast, syngo.CT Extended Functionality is a broader advanced…